Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Capital Employed (2016 - 2025)

Lisata Therapeutics filings provide 12 years of Return on Capital Employed readings, the most recent being 1.09% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 37.0% year-over-year to 1.09%, compared with a TTM value of 1.09% through Dec 2025, down 37.0%, and an annual FY2025 reading of 0.78%, down 21.0% over the prior year.
  • Return on Capital Employed hit 1.09% in Q4 2025 for Lisata Therapeutics, down from 1.06% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.4% in Q2 2023, with the low at 1.09% in Q4 2025.
  • Median Return on Capital Employed over the past 3 years was 0.62% (2024), compared with a mean of 0.69%.
  • The sharpest move saw Return on Capital Employed dropped -5bps in 2024, then plummeted -40bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.52% in 2023, then plummeted by -40bps to 0.72% in 2024, then crashed by -51bps to 1.09% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.09%, 1.06%, and 0.92% for Q4 2025, Q3 2025, and Q2 2025 respectively.